In vitro evaluation o f Transdermal Patch of Palonosetron for Antiemetic Therapy
Keywords:
Palonosetron, Transdermal Drug Delivery System, Serotonin 5-HT3 antagonistAbstract
Skin is one of the routes for systemic delivery of drugs through various drug delivery system. A transdermal Drug Delivery System (TDDS) is one of the most reliable and useful system to deliver drug systemically through skin. Generally medicated patch is placed on skin for delivery of medication through it into the blood stream. The aim of present study was to formulate and evaluate Palonosetron transdermal patch in vitro that could be used for antiemetic therapy. The incorporation ofPalonosetron a serotonin 5-HT3 antagonist drug was envisaged. The TDDS was prepared by solvent evaporation technique and was evaluated for organoleptic characteristics and other physicochemical properties Thickness, Weight variation, Drug content uniformity, Tensile strength, % Elongation, Folding endurance & Moisture content. The in vitro permeation study of the patch was carried out through KesaryChein diffusion cell as barrier membrane. Phosphate buffer pH 7.4 was used as dissolution medium and the temperature was maintained at 37 ± 10C. The in vitro permeation study of the prepared patch indicated a time dependent increase in drug release throughout the study. The percentage of cumulative drug release was found to be 76.25% in 24 hours.The study shows a new approach to work in with Palonosetron.
References
. Prausnitz MR, Langer R. Transdermal
drug delivery. Nature biotechnology.
;26(11):1261-8.
. Chien YW, Swarbrick J. Novel drug
delivery systems. 1992.
. Naik A, Kalia YN, Guy RH.
Transdermal drug delivery:
overcoming the skin’s barrier function.
Pharmaceutical science & technology
today. 2000;3(9):318-26.
. Rajadhyaksha VJ. Penetration
enhancers for transdermal drug
delivery of systemic agents. Google
Patents; 1983.
. Singh J. Transdermal Drug Delivery
Formulation. Google Patents; 2006.
. Dhiman S, Singh TG, Rehni AK.
Transdermal patches: A recent
approch to new drug delivery system.
Int J Pharm Pharm Sci. 2011;3(5):26-
. Yadav V. Transdermal drug delivery
system: Review. International Journal
of Pharmaceutical Sciences and
Research. 2012;3(2):376.
. Klose KT-J, Zhou J, Morgan TM,
Finnin BC, Reed BL. Transdermal
delivery of antiemetics. Google
Patents; 2005.
. Boccia R, Grunberg S, FrancoGonzales E, Rubenstein E, Voisin D.
Efficacy of oral palonosetron
compared to intravenous
palonosetron for the prevention of
chemotherapy-induced nausea and
vomiting associated with moderately
emetogenic chemotherapy: a phase 3
trial. Supportive Care in Cancer.
;21(5):1453-60.
. Segal IS, Jarvis DJ, Duncan SR,
White PF, Maze M. Clinical efficacy of
oral-transdermal clonidine
combinations during the perioperative
period. Anesthesiology.
;74(2):220-5.
. Boekhorst J, Van Tol R. Catapres
transdermal therapeutic system (TTS)
for long-term treatment of
hypertension. Low dose oral and
transdermal therapy of hypertension:
Springer; 1985. p. 106-10.
. Anderson AR, Weikert ML, Crain JL.
Determining the most optimal stage
for embryo cryopreservation.
Reproductive biomedicine online.
;8(2):207-11.
. Prodduturi S, Sadrieh N, Wokovich
AM, Doub WH, Westenberger BJ,
Buhse L. Transdermal delivery of
fentanyl from matrix and reservoir
systems: effect of heat and
compromised skin. Journal of
pharmaceutical sciences.
;99(5):2357-66.
. Jamak V, Ghosh B, Desai B, Khanam
J. Recent trends in transdermal
cardiovascular therapy. Indian journal
of pharmaceutical sciences.
;68(5).
. Chaudhary H, Saini S, Singh G.
Formulation And Evaluation Of
Fexofenadine Hydrochloride
Transdermal Patch. Journal of Drug
Delivery and Therapeutics. 2012;2(5).
. Parashar T, Sachan R, Singh V,
Singh G, Tyagi S, Patel C, et al.
Ethosomes: A recent vesicle of
transdermal drug delivery system.
. Jain S, Mishra D, Kuksal A, Tiwary A,
Jain N. Vesicular approach for drug
delivery into or across the skin:
current status and future prospects.
Pharmacy Online. 2006;1:1-32.
. Kumar S, Nain P, Singh J. Nicotine
addiction and its Pharmacological
effects: A Review. 2011.
. Henningfield JE. Nicotine medications
for smoking cessation. New England
Journal of Medicine.
;333(18):1196-203.
. Lewis S, Udupa N. Design and
evaluation of matrix type and
membrane controlled transdermal
delivery systems of nicotine suitable
for use in smoking cessation. Indian
journal of pharmaceutical sciences.
;68(2).
. Jain SK, Vyas SP, Dixit V. Salbutamol
delivering transdermal dosage form
based on osmo-regulatory principle.
Drug Development and Industrial
Pharmacy. 1990;16(9):1565-77.
. Prabhakar D, Sreekanth J, Jayaveera
K. Transdermal drug delivery patches:
a review. Journal of Drug Delivery and
Therapeutics. 2013;3(4):231-21.
. Can AS, Erdal MS, Güngör S, Özsoy
Y. Optimization and characterization
of chitosan films for transdermal
delivery of ondansetron. Molecules.
;18(5):5455-71.
. Suryadevara P. Formulation and
Evaluation of antiemetic patch
comprising Ondansetron
hydrochloride. Rajiv Gandhi University
of Health Sciences, Karnataka,
Banglore. 2010;58.
. Reddy KR, Mutalik S, Reddy S. Oncedaily sustained-release matrix tablets
of nicorandil: formulation and in vitro
evaluation. AAPS pharmscitech.
;4(4):480-8.
. Haigh JM, Smith EW. The selection
and use of natural and synthetic
membranes for in vitro diffusion
experiments. European journal of
pharmaceutical sciences. 1994;2(5-
:311-30.
. Shah V, Raval S, Peer S, Upadhyay
U. A comparative evaluation of
different membranes for their diffusion
efficiency: an in vitro study. Pharma
Science Monitor-An International
Journal Pharmaceutical Sciences.
;1(1):41-9.
